Skip To Main Content
This website contains promotional content and is intended for Healthcare Professionals in the Republic of Ireland only. Adverse event reporting can be found at the bottom of the page
Campus
Campus

Curated Science

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

Sort by

Filters

Reset
  • Therapeutical Areas
ESC/EAS Dyslipidaemia Guidelines Interactive Tool (20 Minutes)

ESC/EAS Dyslipidaemia Guidelines Interactive Tool (20 Minutes)

20 minutes

We know your time is precious, how long do you have?

Learn more
T1 Evidence in Children

T1 Evidence in Children

Learn more
T1 Edition Junior Study

T1 Edition Junior Study

Learn more
T1 Evidence in Adults

T1 Evidence in Adults

Learn more
InRange Study

InRange Study

Learn more
ORION Observational Study

ORION Observational Study

Learn more
BRIGHT study

BRIGHT study

Learn more
SPARTA Study

SPARTA Study

Learn more
T1DM - Meta-Analysis

T1DM - Meta-Analysis

Learn more
What are the benefits of rosuvastatin?

What are the benefits of rosuvastatin?

Learn more
What are the benefits of adding ezetimibe?

What are the benefits of adding ezetimibe?

Learn more
What is the efficacy and safety profile of ezetimibe/rosuvastatin combination?

What is the efficacy and safety profile of ezetimibe/rosuvastatin combination?

Learn more

Our Products

Suvezen® Product Page

Click here for Prescribing Information

 

MAT-IE-2300173 (v3.0)
Date of preparation: April 2024

Toujeo® Product Page

Click here for Prescribing Information

 

MAT-IE-2300465 (v1.0)
Date of preparation: July 2024

Lantus® Product Page

Click here for Prescribing Information

 

MAT-IE-2300466 (v1.0)
Date of preparation: May 2024

MAT-IE-2300165 (v3.0)
Date of preparation: July 2024